Company / Interest Expense
SELLAS Life Sciences Group, Inc. Interest Expense History
FY2017-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$6.0K
FY2022
5-year range
$6.0K / $26.0K
FY2018-FY2022
Trend
-76.9%
vs FY2021
Sector context
#40 of 44
Health Care
What the data says
Among 44 Health Care companies, SELLAS Life Sciences Group, Inc. is in the top 9% for interest expense. Improved from $118,000 to $6,000 over the past 3 years.
Based on SEC 10-K filings.
$6,000 in FY2022 with a 3-year CAGR of -63.0%.
Improved from $118,000 to $6,000 over the past 3 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -63.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 44This company $6.0K Sector average $291.0M
▼
-100.0% below sector average
Key checks
Key Insights
- 3-year CAGR of -63.0%, indicating a declining trend.
- In FY2022, interest expense decreased 76.9% year-over-year.
- Ranks #40 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $6.0K | -76.9% |
| FY2021 | $26.0K | - |
| FY2020 | - | - |
| FY2019 | $118.0K | +144.4% |
| FY2018 | -$266.0K | +42.4% |
| FY2017 | -$462.0K | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026